Deliver Better
Enrollment Performance.

Improve the Clinical Handoff

Make Your Existing Recruitment Strategy More Effective.

AiSync adds a clinical evidence verification layer between patient identification and site screening—improving referral quality, resolving evidence gaps, and supporting more efficient study execution.

Recruitment

Patient identification and engagement

• Patient identification
• Prescreening and outreach
• Patient engagement
• Recruitment partners and campaigns

Clinical verification layer

We retrieve, verify, and organize the right clinical evidence before it reaches your sites.

1. 1

   Retrieve Records

   Collects available records from National Exchanges and identifies gaps.

3. 2

   Resolve Gaps

   Targets specific providers for missing clinical evidence.

5. 3

   Evaluate Evidence

   Assesses records against protocol inclusion and exclusion criteria.

7. 4

   Clinical Summary

   A clear, source-cited summary with PASS / PASS WITH EXCEPTION / FAIL.

Research site review

Investigator eligibility decision

• Complete, organized clinical evidence
• Protocol-aligned summary
• Source-cited hyperlinks to records
• Investigator retains final eligibility authority

• Higher Quality Referrals More complete clinical evidence before site review.
• More Efficient Site Screening Sites spend less time on record retrieval and manual review.
• Works With Your Existing Strategy Complements your recruitment partners, systems, and site workflows.
• Scalable and Flexible Study-specific deployment and integration options.

Stronger Site Performance

Give Sites a Head Start on Clinical Review.

AiSync reduces the manual record retrieval and pre-screening burden for research site coordinators by delivering a clear, organized, protocol-aligned evidence package—so they can focus on the tasks only they can perform.

HISTORICAL PHASE III COPD PROGRAM

Defined Coordinator Tasks: 180 Minutes → 35 Minutes Per Referral

BEFORE180 min

Defined coordinator tasks per referred patient

WITH AISYNC35 min

Same task scope in the historical comparison

80.6%Reduction in defined coordinator task time. Approximately 894 coordinator-hours of capacity across 370 referrals, based on the reported before-and-after task estimates. Not necessarily realized labor-cost savings.

FASTER TIME TO FIRST VISIT15 days → 5 days

Referral to first visit in the historical COPD program.

• More Productive CoordinatorsLess time spent on record retrieval and manual review.
• Higher Quality ReferralsSites receive organized, source-cited clinical evidence.
• Faster Site ScreeningShorter time from referral to investigator review.
• Supports Site RelationshipsHelps reduce site burden and improves the overall experience.

Flexible Commercial Deployment

Build a Stronger Enrollment Strategy Into Your Next Proposal.

AiSync can be incorporated into new study proposals, active studies, or long-term CRO partnerships—providing a study-specific approach, clear deliverables, and measurable value.

New Study Proposals

Differentiate your enrollment strategy with protocol-specific clinical verification.

• Protocol-to-evidence blueprint
• Workflow integration options
• Study-specific budget and value model

Active Study Support

Introduce AiSync where referral quality or screening inefficiency needs attention.

• Targeted verification cohorts
• Define success measures
• Rapid deployment with measurable impact

Strategic Partnerships

Establish repeatable workflows across studies and sponsors.

• Preferred vendor relationships
• Standardized playbooks
• API integration options

Site Strategy

Implementation Plan

1. 1Protocol analysis and evidence mapping
2. 2Workflow design and integration
3. 3Pilot deployment and performance tracking
4. 4Scale and ongoing support

Protocol Readiness & Enrollment Strategy

STUDY-SPECIFIC ANALYSIS

Evidence Requirements

Category	Key Evidence	Lookback
Diagnosis	Clinical notes, labs	5 years
Prior therapies	Medication history	2 years

Evidence Source Map

National ExchangesBroad electronic access

Provider RetrievalTargeted retrieval

Projected Impact

Higher quality referrals

Faster time to evaluation

• Strengthen ProposalsProvide a differentiated, execution-ready enrollment strategy.
• Support Study ExecutionImprove referral quality and reduce downstream inefficiency.
• Deliver Measurable ValueAlign on clear assumptions and performance measures.
• Enable Long-Term PartnershipsBuild repeatable workflows across studies and sponsors.

Built to Work Together

Flexible Implementation. Seamless Integration.

AiSync complements your existing recruitment partners, site networks, and clinical systems—fitting seamlessly into your current workflows to strengthen the clinical evidence handoff.

01

Recruitment Ecosystem

Patient identification and engagement

• Patient engagement
• Prescreening
• Recruitment partners
• Site networks

02

Referral to AiSync

HIPAA authorization and record retrieval

HIPAAAuthorized

03

CLINICAL EVIDENCE VERIFICATION

• National Exchanges and digital connections
• Targeted provider retrieval and gap resolution
• Protocol-aligned evidence evaluation
• AiSync Clinical Summary with page-cited hyperlinks

04

Site Review

Investigator eligibility decision

05

Study Execution

Improved referral quality and site productivity

• Higher quality referrals
• More efficient screening
• Reduced site burden
• Faster time to evaluation

• Complements Your EcosystemWorks with your existing recruitment and site partners.
• Fast and FlexibleDeploy quickly with scalable options.
• Secure and CompliantHIPAA-aligned processes and audit-ready documentation.
• Built for Long-Term SuccessRepeatable workflows across studies and sponsors.

Real Results for CROs

Measurable Impact
Across the Enrollment Journey.

Independent third-party analysis by a top-3 global CRO demonstrates significant improvements in key enrollment outcomes with AiSync.

• Higher Quality ReferralsMore eligible patients reach sites and consent.
• More Efficient SitesLess time on manual review and fewer unnecessary visits.
• Faster Study ExecutionShorter time to evaluation accelerates enrollment timelines.
• Scalable ImpactProven across multiple studies, therapeutic areas, and site networks.